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The combination of ultrasonic nebulization with membrane desolvation
(USN-MD) is utilized to determine active pharmaceutical ingredients
(API) by heteroatom inductively coupled mass spectroscopy (ICP-MS)
detection. Ultrasonic nebulization provides efficient sampling while use of
the membrane desolvator acts to reduce solvent-based interferences. This
approach reduces interferences sufficiently so that a standard argon ICP-
quadrupole MS can be utilized. Examined APIs and associated
heteroatoms included: phosphomycin (P), amoxicillin (S), chlorpropamide
(Cl), and ofloxacin (F). The optimum plasma r.f. powers for P, S, and Cl
were in the 1000 to 1200 watts range. The high ionization energy of F
required that the plasma be operated at 1500 W. The 16O2þ interference at
mass 32 precluded determinations using the sulfur-32. The sulfur-34
(4.2% natural isotopic abundance), however, was relatively free of
isobaric interferences. Interferences were relatively small at the mass 35
isotope of Cl, but increased with higher ICP r.f. powers. Overlaps were
significant at the masses of monoisotopic species, fluorine-19 and
phosphorus-31. Detection limits for P, S, Cl, and F of 2, 3, 90, and 3000
ng/mL, respectively, were generally lower than those produced with other
quadrupole systems and comparable to or better than values published
utilizing high-resolution instruments.
Index Headings: Ultrasonic nebulization; Membrane desolvation; USN-
MD; Inductively coupled plasma mass spectrometry; ICP-MS; Elemental
analysis; Heteroatom determination; Pharmaceutical; Direct solution
introduction.
INTRODUCTION
In many applications where trace determinations of metals
and metalloids are required, inductively coupled plasma mass
spectrometry (ICP-MS) has become the instrument of choice.
Calculations based upon the assumption that the plasma has a
temperature of 7500 K and an electron density of 1015/cm3
show that the argon ICP efficiently ionizes most metals to
values exceeding 90% to provide a large pool of ions that can
be analyzed by mass spectrometry.1
The sensitivity of ICP-MS decreases markedly when non-
metals are determined. A dominant reason for this loss of
sensitivity can be attributed to the higher ionization potentials
of these elements. For example, with the specified ICP
conditions, it can be calculated that 9 3 104% of fluorine
should be ionized; chlorine ionization is only 0.9%.1 Addi-
tionally, water, nitrogen, and organic solvent decomposition
products yield low molecular weight polyatomic ions. These
ions produce mass spectral overlaps with lower resolution
quadrupole mass analyzers typically utilized in ICP-MS. For
example, O2
þ directly overlaps the major isotope of sulfur, 32S
(95.0% isotopic abundance). A number of these interferences
for F, P, S, and Cl are listed in Table I, along with the isotopic
abundances of those species.
In spite of these issues, successes have been seen. Using
ultrasonic nebulization and quadrupole MS, Jiang and Houk2
obtained detection limits in the range of 150 ppb monitoring
34Sþ (4.22% isotopic abundance). In the same paper, a
phosphorus detection limit of 8 ppb was obtained. While these
numbers do not fall into the ppt range of a number of metals,
these detection limits are certainly respectable.
A number of strategies have been employed to overcome the
limitations of direct solution nebulization with commercially
available instruments. The general focus has been to reduce or
avoid the spectral interferences and enhance analyte transport
to the discharge. These approaches include employing higher
resolution mass spectrometers,3–6 utilizing pre-quadrupole MS
collision cells,7 using mixed gas8 and low pressure helium
plasmas,9,10 and applying various nebulization and analyte
stream desolvation approaches.
The use of the higher resolution provided by sector
instruments allows separation of ions of the same nominal
mass, based upon mass defects. For instance, Bu, Wang, and
Hall3 illustrate that 19Fþ (18.9984 amu) can be mass spectrally
differentiated from 1H3
16Oþ (19.00699 amu). This advantage
provided improved detection limits for chlorine and fluorine.
Other workers have also used sector instruments to determine
sulfur4,5 and phosphorus.6 Despite the greater mass resolution,
these higher resolution instruments possess some disadvan-
tages compared to quadrupole instruments. Sector instruments
are generally larger and require lower operational pressures.
Maximization of resolution may cause further ion loss that may
limit the sensitivity of the instrument.3
Collision and reaction cells have been successfully used to
reduce spectral interferences commonly found in ICP-MS
spectra.11 These techniques involve the interaction of post-
plasma analyte ions with gases in an appropriate multipole
reaction cell. These collisions, through judicious choice of
reagent gas, can induce ion neutralization, charge transfer, and/
or the formation of analyte containing molecular ions. The
objective is to reduce the intensity of the interferent peak or
separate the analyte ion peak from the interferent by formation
of molecular adducts of either the interferent or analyte peak.11
The detection of sulfur12,13 and phosphorus12 as their oxides
has been demonstrated using these approaches. These techni-
ques suffer from enhanced complexity and ion loss that may
limit sensitivity.
Helium and mixed-gas ICP have been used to overcome
polyatomic interferences and enhance ionization for the
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detection of metals and nonmetals.8–10,14 The use of He as the
carrier gas for ICP-MS has advantages such as better detection
limits for nonmetals because of the higher energies of He
plasma species. Sheppard, Shen, Davidson, and Caruso8
obtained significant detection limit enhancements for halogens
using a 70:30 Ar:He plasma gas. However, there are some
drawbacks to using mixed gas and pure He plasma gases. For
instance, it is more difficult to form and contain the He plasma,
in part because the thermal conductivity of He is higher than
that of Ar. Also, the He plasma has a lower gas temperature
and electron density compared to Ar-plasma. Secondary
discharges in the expansion region, which reduce analyte ion
transport efficiency to the detector, are also more pronounced
for He than Ar plasmas. That problem is, by far, the limiting
factor for the detection of hard-to-ionize nonmetals.15 Since the
major background ions present in a He plasma are the low-
mass ions,14 this problem may be more significant for certain
low-mass nonmetals, especially fluorine. If a commercial Ar-
ICP-MS is to be used as a He-ICP-MS, significant instrumen-
tation modifications (e.g., impedance matching network, load
coil modifications, sample and skimmer cone spacing, etc.)
may be necessary to obtain optimum performance.
An alternate route to improving nonmetal ICP-MS detection
limits is to enhance analyte transport to the plasma. ICP-MS
instruments typically use pneumatic nebulizers for aerosol
production. In comparison, ultrasonic nebulizers (USN) are
more efficient in that they produce a larger volume of sample
mist to increase analyte flux to the plasma. However, enhanced
analyte delivery to the plasma is often accompanied by
additional solvent liquid volume and vapor. This is true even
in cases where the USN flow stream is directed through a
heater–condenser combination to reduce solvent flux. Higher
ionization energy elements, such as nonmetals, are more
susceptible to interferences and ionization quenching caused by
solvent effects upon the plasma. This is especially true in the
case of organic solvents.
Additional continuous desolvation approaches are in order.
An approach that has proven advantageous in atomic
spectroscopy is the use of membrane desolvation (MD).16–18
With this technique, the analyte-containing solvent flow stream
is heated to evaporate the solvent and produce analyte-
containing particulates. Solvent vapor is removed by osmotic
pressure induced diffusion through a microporous membrane,
often composed of polytetrafluoroethylene (PTFE), to a region
continuously swept by a dry external countercurrent gas
stream. Our research group has applied USN-MD to the
analysis of chlorine containing organic compounds using LC
coupled with microwave induced plasma atomic emission
spectrometry.19–21 MD in combination with USN has been
utilized for the liquid chromatographic ICP-MS determination
of phospholipids dissolved in organic solvents.22 Detection
limits with the USN-MD system were determined.
The focus of this work is to characterize and compare the
analytical performance of USN-MD sample introduction for
the determination of sulfur, phosphorus, chlorine, and fluorine
containing organic pharmaceutical model compounds using
conventional Ar-ICP-MS with a quadrupole mass analyzer.
Target analytes are the active pharmaceutical ingredients:
phosphomycin (P), amoxicillin (S), chlorpropamide (Cl), and
ofloxacin (F).
EXPERIMENTAL
A schematic diagram of the experimental system is shown in
Ref. 23. Highlights of the system are detailed below.
Sample Introduction. Flow injection sample volumes of
100 to 300 lL were introduced to a CETAC U5000 USN
(CETAC Technologies, Omaha, NE) using a Gilson Minipuls3
peristaltic pump (Gilson, Inc., Middleton, WI). The liquid flow
rate was 0.9 mL/min. While maximum steady-state signals
were not obtained with this approach, the limited sample
volumes avoided analyte residue buildup within the system and
allowed multiple parameters to be varied in reasonable time
frames. Following the heating–condensation USN apparatus,
the nebulized mist was further desolvated utilizing a CETAC
MDX-100 PTFE membrane desolvator. Operational parame-
ters are listed in Table II. The desolvated samples were
transported to the plasma by the argon gas.
Inductively Coupled Plasma Mass Spectrometry and
Data Acquisition. A Fisons (Thermo Electron, Madison, WI)
Instruments PlasmaQuad II ICP-MS was used to perform mass
analyses. The detector was a Burle Electrooptic, Inc. (Stur-
bridge, MA) channeltron model number 4870V. Data was
acquired utilizing Thermo Electron PlasmaLab software
(Version 1.06.007, Ionflight, Boston, MA). Both the single
ion monitoring and scanning modes were used. Mass spectra
(scanning mode) were obtained to confirm the peak positions
for each element. Background and analyte signals were
determined using 30 second single ion monitoring observations
at a rate of 250 ms/point. Detection limits were calculated as
the concentrations giving a signal three times the standard
deviation of the background signal. Additional data acquisition
parameters are summarized in Table II.
Reagents and Sample Preparation. An 80 ppm phospho-
rus-containing stock solution was prepared by dissolving an
appropriate mass of phosphomycin calcium salt (Sigma-
Aldrich, Milwaukee, WI) in deionized water. A 50 ppm
sulfur-containing stock solution was prepared by dissolving the
appropriate mass of amoxicillin (Sigma-Aldrich, Milwaukee,
WI) in aqueous 0.2% HNO3. A 60 ppm chlorine-containing
stock solution was prepared by dissolving chlorpropamide
(Sigma-Aldrich, Milwaukee, WI) in aqueous 0.02 M KOH. A
500 ppm fluorine-containing stock solution was prepared by
dissolving ofloxacin (Sigma-Aldrich, Milwaukee, WI) in a 4%
























































NH3 solution. The structures of these compounds are shown in
Fig. 1. The stock solutions were used to prepare diluted
solutions with appropriate solvents for analyses. HPLC grade
methanol (Sigma-Aldrich, Milwaukee, WI) and 18 MXcm
deionized water obtained with a Millipore Systems (Billerica,
MA) Milli-Q Plus deionization system were used for sample
preparation. Details are provided in the individual sections
regarding the elements.
RESULTS AND DISCUSSION
Solvent Composition. The analytes in this study are
pharmaceutical compounds that would often be determined in
aqueous based chromatographic mobile phases using organic
modifiers and/or ion or pH buffers. As such, various solvent
compositions were examined. These results are presented as
part of a systematic study in which the behaviors of each solvent
system with USN-MD sample introduction are detailed.23 The
solvent compositions listed for each analyte in Table III
represent those that produced the best signal-to-noise ratios.
Background Interferences and Isotope Selection. The
detection limit for many elements in ICP-MS is greatly
influenced by interferences present at the particular m/z value.
The background ion count depends on the plasma chemistry,
which varies with operational conditions, the composition of
the analyte solution matrix, and the argon purity. This solution
may contain high concentrations of an interfering ion or a
combination of elements that combine under the correct
conditions to produce high molecular ion backgrounds.
Elimination of solvent interferents requires complete des-
olvation of the analyte stream so that only dry, particulate
analyte molecules are transported to the plasma. As shown in a
number of other publications, solvent transport measure-
ments19 and molecular emission spectra20,21 illustrate the high
solvent removal characteristics of membrane desolvation
systems coupled with an ultrasonic nebulizer.
However, solvent removal is not 100%. Figure 2 illustrates
mass spectra taken at the m/z ratios corresponding to the
analytes with nebulized solvent with and without analyte. The
signal at mass 32 was unusable for the dominant ion of sulfur
(95.0% abundance) due to the background signal caused by
16O2
þ. However, the background signal was less than 200
counts per second for the less mass abundant 34S (4.2%)
species. Chlorine-35, the most abundant isotope, produced the
best chlorine signal-to-noise ratio with a background signal of
less than 5000 counts per second. However, the background
was significant for the monoisotopic species 31P and 19F. At
mass 31 (phosphorus), it is likely that the significant
background is caused by nitrogen impurities and products of
methanol decomposition. Due to the isotope abundances, likely
candidates are 14N16O1Hþ and 12C16O1H3þ. At mass 19, it has
been shown that background contributions from 16O1H3
þ and
18O1Hþ are substantial.4 Examinations of the ratios of the small
background signals at m/z ¼ 19 and 20 indicate that 38Arþ2 is
not a significant interferent. The discussed species and other
possible, but less likely, interferents are noted in Table I.
TABLE II. ICP-MS and sample introduction operational parameters.
Sample introduction
Peristaltic pump liquid sample introduction
flow rate
0.9 mL/min
Sample volume 100–300 lL
Ultrasonic nebulizer argon flow rate 0.62 L/min
Post ultrasonic nebulizer flow stream heater
temperature
140 8C
Post ultrasonic nebulizer flow stream condenser
temperature
3 8C
Membrane desolvator countercurrent argon flow
rate
1.9 L/min
Membrane desolvator flow stream heater
temperature
160 8C
Inductively coupled plasma mass spectrometer
Argon plasma gas flow rate 0.8 L/min
Argon plasma coolant flow rate 14.0 L/min








Data acquisition mode Single ion–pulse counting
Data acquisition dwell time 250 ms
a Discussions regarding forward power and isotope selection are contained in
the text.
FIG. 1. Structures of (a) phosphomycin, (b) amoxicillin, (c) chlorpropamide, and (d) olfoxacin.
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Phosphorus Determinations. Optimization of the phos-
phorus-31 signal, introduced as phosphomycin in a 20%
methanol in water solution, consisted of varying gas flow rates
and the forward power to maximize the signal-to-noise ratio.
Because phosphorus will be significantly ionized under typical
plasma operating temperatures, 33% as estimated by Houk,1
the plasma provides a relatively large abundance of ions for
measurement. As seen in Table III, the detection limit is
reasonably low at 1.7 ng/mL. That the detection limit does not
rival those of metals with similar ionization energies may be
due to analyte decomposition issues; phosphorus atomization
requires multiple oxygen–phosphorus bond breakages. This
speculation is countered by the absence of significant POþ,
PO2
þ, or PO3þ signals. However, in the presence of
phosphorus, a significant signal at m/z ¼ 48 was seen. It is
likely that this signal is due to POHþ. Phosphorus detection
limits for this and other continuous liquid sample introduction
ICP-MS approaches can be seen by examination of Table IV.
In all cases, the present detection limits using the USN-MD are
superior. The improvement compared to other published
values1,2,6,9 may be attributed to enhanced desolvation of the
analyte stream, which limits plasma cooling and minimizes the
formation of polyatomic interferents. Utilizing pulse counting,
the calibration plot was linear from 20 to 800 ng/mL with an r2
value of 0.9992. Using analog detection, the range could be
extended from 800 to 4000 ng/mL.
Sulfur Determinations. As noted in the Background
Interferences subsection, determinations observing the most
abundant isotope for sulfur (32S) were precluded due to the
large 16O2
þ ion background. Although the mass 34 isotope is
much less abundant (4.2%), the concomitant decrease in the
background ion count produced signal-to-noise ratios superior
to those achieved using the mass 32 isotope. Some interfer-
ences are still present at mass 34 (Table I); however, the net
effect is a relatively small background signal. It was found that
operation of the plasma at 1200 W provided the best signal-to-
noise ratios for sulfur. This power served to enhance the
ionization of sulfur, which is ionized only 14% based upon
Houk’s1 previously calculated values. The detection limit was
determined to be 3.3 ng/mL and is listed in Table III. Again, as
with phosphorus, the sulfur detection limit was superior to
those obtained with other methods with the standard plasma
sample-and-skimmer-cone plasma quadrupole mass spectrom-
eter interface. It should be noted that the use of a pre-
quadrupole octopole dynamic reaction cell7 or a sector mass
spectrometer4,5 produced somewhat better detection limits. The
trade-off of the relative complexities of high resolution mass
spectrometry with ultrasonic nebulization and membrane
desolvation must be made. Utilizing pulse counting, the
calibration plot was linear from 10 to 1000 ng/mL with an r2
value of 0.997. Using analog detection, the range could be
extended from 1000 to 5000 ng/mL.
TABLE III. Summary of analytical performance of detection of nonmetals using ICP-MS with ultrasonic nebulization and membrane desolvation.
Compound Monitored isotope Solventa Sensitivity (icps/ng)b Detection limit (ng) Detection limit (ng/mL)
Phosphomycin 31P 20% CH3OH 20 700 0.3 2
Amoxicillin 34S 20% CH3OH 1800 0.3 3
Chlorpropamide 35Cl 0.1% CH3COONH4 400 9 90
Ofloxacin 19F 4% NH4OH 0.55 1000 3000
a Aqueous solvent mixture with specified components.
b icps¼ integrated counts per second.
FIG. 2. Mass spectra of (a) 31P (4 ppm P as phosphomycin), (b) 34S (580 ppb S as amoxicillin), (c) 35Cl (6 ppm Cl as chlorpropamide), and (d) 19F (100 ppm F as
ofloxacin), indicating background (lower lines) and analyte (upper lines) peaks. Experimental conditions as listed in Table II.
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Chlorine Determinations. The most abundant chlorine
isotope, 35Cl, was monitored. As seen in Fig. 2, this isotope is
relatively free of interferences. Bu, Wang, and Hall4 noted
similar behavior. With the fairly low calculated ionization
efficiency for chlorine, ;0.9%,1 higher forward powers were
initially used when examining the chlorpropamide-containing
samples. However, the increase in forward power resulted in an
increase in the background ion signal and noise, degrading
detection limits. Based upon available information, the nature
of the interference is not clear. The optimal plasma power for
chlorine detection was 1000 W. A detection limit of 90 ng/mL
was obtained (Table III). Utilizing pulse counting, the
calibration plot was linear from 180 to 60 000 ng/mL with an
r2 value of 0.99991.
These authors found no other chlorine detection limits with
direct solution sampling into a standard argon ICP quadrupole
mass spectrometer system. Again, that chlorine was detectable
at these levels is attributed to the USN-MD system. Using a
sector mass spectrometer, Bu and Hall3 obtained detection
limits of 3 ng/mL. Sheppard, Shen, Davidson, and Caruso8
were able to reduce detection limits to 2.2 ng/mL with a mixed
argon–helium plasma.
Fluorine Determinations. Fluorine has the highest ioniza-
tion energy of all the halogens. The calculated ionization
efficiency is only 9 3 104%.1 Additionally, with significant
water and argon derived interferences possibly present at the
mass of it’s only isotope, fluorine-19 determinations have
presented a significant challenge for ICP-MS spectroscopists.
Even with MD in the present study, the background signal is
significant. Increasing the forward power to 1500 W served to
maximize the signal-to-noise ratio by enhancing the fluorine
ion signal. Powers exceeding 1500 W increased the back-
ground noise without further significant increases in the 19Fþ
signal.
Although this is the first report of solution sample
introduction directly into a conventional ICP-MS system, the
detection limit of 3300 ng/mL is high compared to the other
nonmetals discussed in this study. As illustrated in Table IV,
this value is comparable to, or slightly better than, published
results using a low pressure helium ICP9 or an argon plasma
with a sector mass analyzer.4 While the sector instrument
produced higher resolution than the quadrupole mass spec-
trometer used in this study, it can be presumed that the sector
MS tradeoff between resolution and reduced ion flux and
reduced water-derived interferences with membrane desolva-
tion is the reason that the our detection limits are comparable.
Utilizing pulse counting, the calibration plot was linear from 50
to 200 lg/mL with an r2 value of 0.98. At higher
concentrations, a calibration plot rollover occurred. While
detailed studies of this phenomenon are required to fully
understand the cause of this rollover, it is highly possible that
charge-repulsion effects involving the lower mass fluorine ion
may play a major role.
CONCLUSION
Determinations of phosphorus, sulfur, chlorine, and fluorine
heteroatoms containing active pharmaceutical ingredients have
been demonstrated using ICP-MS coupled with ultrasonic
nebulization and membrane desolvation. A general trend of
decreasing detection limits with increasing ionization effi-
ciency was observed. Detection limits in the sub- to few ng/mL
range were obtained for P, S, and Cl. The detection limit for F
was 3300 ng/mL. For these elements, these are the best
detection limits reported with continuous solution nebulization
and a standard argon ICP-MS. These detection limits can be
attributed to the high efficiency of ultrasonic nebulization
combined with a reduction of matrix-induced interferences by
the membrane desolvation system. This sample introduction
system provides a simple and effective way to enhance ICP-
MS performance for nonmetal determinations.
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